This scientific commentary refers to 'c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma' by Luo et al. (doi: 10.1093/brain/awv287)
科研之友
微信
新浪微博
Facebook
分享链接
